The Linnea Research and Development team provide essential support to the business through the identification of new active principles and development of innovative extraction and synthesis technologies. These technical and scientific advances are the core of the company’s know-how and patent portfolio.

Isolation of active ingredients and development of industrial processes for third party companies are services that are also provided on a contract or partnership basis.

The Linnea Research and Development team also works closely with the major pharmacopeias – notably the USP and EP – in the development of global product standards and analytical methods, most recently contributing to the EP monograph for Vinpocetine and the USP monographs for Red Clover extract and Vinpocetine.